Jacob Thaysen
Net Worth
Last updated:
What is Jacob Thaysen net worth?
The estimated net worth of Mr. Jacob Thaysen is at least $25,302,432 as of 1 Dec 2022. He owns shares worth $10,144,971 as insider, has earned $7,506,901 from insider trading and has received compensation worth at least $7,650,560 in Agilent Technologies, Inc..
What is the salary of Jacob Thaysen?
Mr. Jacob Thaysen salary is $956,320 per year as Senior Vice President and Pres of Life Sciences & Applied Markets Group in Agilent Technologies, Inc..
How old is Jacob Thaysen?
Mr. Jacob Thaysen is 50 years old, born in 1975.
What stocks does Jacob Thaysen currently own?
As insider, Mr. Jacob Thaysen owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Agilent Technologies, Inc. (A) | Senior Vice President and Pres of Life Sciences & Applied Markets Group | 84,464 | $120.11 | $10,144,971 |
What does Agilent Technologies, Inc. do?
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Jacob Thaysen insider trading
Agilent Technologies, Inc.
Mr. Jacob Thaysen has made 7 insider trades between 2017-2022, according to the Form 4 filled with the SEC. Most recently he sold 3,235 units of A stock worth $503,528 on 1 Dec 2022.
The largest trade he's ever made was exercising 22,583 units of A stock on 28 Nov 2017. As of 1 Dec 2022 he still owns at least 84,464 units of A stock.